Skip to search formSkip to main contentSkip to account menu

dapiprazole

Known as: Dapiprazolum, Dapiprazol, 1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Purpose. The authors investigated the use of dapiprazole, an alpha-adrenergic blocking agent, in preventing pigment release and… 
1996
1996
PURPOSE In this investigation the authors studied the effect of dapiprazole, an alpha-adrenergic blocking agent, on aqueous humor… 
1995
1995
Abstract• Background: Since dapiprazole on alpha-adrenergic agent, produces miosis by paralyzing the dilator muscle, and… 
1993
1993
BACKGROUND Clinical interest in ophthalmic agents to reverse pharmacologically induced mydriasis safely has been attempted for… 
1993
1993
A study was performed to evaluate the clinical usefulness of dapiprazole in a private clinical setting. This study was unmasked… 
1990
1990
The effect of topical dapiprazole, an alpha-adrenergic receptor blocker, in reversing mydriasis was studied in 50 subjects who… 
1988
1988
Trazodone and dapiprazole displace ligands binding to rat brain alpha-1 adrenoceptors. The displacement of 3H-ligands to alpha-2… 
1982
1982
The effects of 3-[2-[4-(2-methylphenyl)-1- piperazinyl]ethyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine HCl (dapiprazole… 
1982
1982
A study of the general pharmacology of 3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3…